New endocrine therapies for breast cancer
- 30 April 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (4), 576-588
- https://doi.org/10.1016/0959-8049(96)00032-9
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trialBreast Cancer Research and Treatment, 1994
- The human estrogen receptor has two independent nonacidic transcriptional activation functionsCell, 1989
- The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation functionCell, 1988
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifenEuropean Journal of Cancer and Clinical Oncology, 1985
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- SYNTHETIC ŒSTROGENS IN MAMMARY CANCERThe Lancet, 1949
- Influence of Synthetic Oestrogens on Advanced Malignant DiseaseBMJ, 1944
- The mechanism of pancreatic secretionThe Journal of Physiology, 1902
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896